1,299 results on '"Savarino, E."'
Search Results
52. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study
53. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
54. Optimal management of constipation associated with irritable bowel syndrome
55. The added diagnostic value of postreflux swallow‐induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on‐therapy impedance‐pH monitoring
56. N012 Nursing interventions for fatigue in IBD: A systematic literature review
57. N014 The impact of nursing care on quality of life in IBD patients: A cross-sectional study
58. N010 Impact of adalimumab’s patient support program on adherence to anti-TNFα therapy in patients with inflammatory bowel disease: A single-centre analysis
59. N005 Specialist nursing interventions for inflammatory bowel disease
60. Letter: oesophageal histological abnormalities and GERD ‐ an underestimated relationship requiring more attention
61. T.01.1 APPLICATION OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS: EVALUATION OF PATIENTS WITH INCONCLUSIVE DIAGNOSIS AND NEW IMPEDANCE-PH PARAMETERS
62. T.01.6 STRAIGHT LEG RAISE TEST: A NOVEL PROVOCATIVE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE AT HIGH-RESOLUTION MANOMETRY
63. T.06.2 MANAGEMENT AND OUTCOME OF CHECK-POINT INHIBITORINDUCED COLITIS: A MULTICENTRE RETROSPECTIVE STUDY
64. OC.05.4 SYSTEMATIC REVIEW WITH META-ANALYSIS: ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF ESOPHAGEAL DISEASES
65. T.01.3 ASSOCIATION BETWEEN POST-REFLUX SWALLOW-INDUCED PERISTALTIC WAVE (PSPW) INDEX AND ESOPHAGEAL MUCOSAL INTEGRITY IN PATIENTS WITH GERD SYMPTOMS
66. OC.03.3 EOSINOPHILIC ESOPHAGITIS: MOST NON-RESPONDERS TO FIRST COURSE OF PPIS ACHIEVE SUSTAINED HISTOLOGICAL REMISSION FOLLOWING SEQUENTIAL TREATMENT WITH TOPICAL STEROIDS AND SECOND COURSE OF PPIS MONOTHERAPY
67. OC.11.5 IMPACT OF REFLUX BURDEN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY ACCORDING TO THE CRITERIA PROPOSED BY CCV4.0 COMPARED TO CCV3.0
68. Nonachalasic esophageal motor disorders, from diagnosis to therapy
69. Small intestine neuromuscular dysfunction in a mouse model of dextran sulfate sodium-induced ileitis: Involvement of dopaminergic neurotransmission
70. Digestive diseases. 2022-2025 edition
71. Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (Journal of Neurology, (2022), 269, 10, (5606-5614), 10.1007/s00415-022-11269-7)
72. Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials: Future Treatments for EGIDS: Systematic Review
73. Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry
74. DOP016 Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study
75. P044 Enteric dopaminergic pathways in mouse and human intestinal inflammation
76. P119 Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series
77. P014 Impact of experimental ileitis and Toll-Like Receptor 4 signaling on enteric inhibitory neurotransmission
78. P647 Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series
79. Erratum to: United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis (United European Gastroenterol J, (2021), 9, 3, (287–306), 10.1002/ueg2.12060)
80. Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohnʼs disease
81. Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study
82. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure
83. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value?
84. Management of patients with gastrointestinal bleeding
85. OC.01.5 RAPID DRINK CHALLENGE DURING HIGH RESOLUTION MANOMETRY IS USEFUL TO PREDICT ESOPHAGEAL EMPTYING IN ACHALASIA PATIENTS AFTER TREATMENT
86. AF.16 DIAGNOSTIC DELAY AND MISDIAGNOSIS IN EOSINOPHILIC ESOPHAGITIS
87. AF.15 EOSINOPHILIC ESOPHAGITIS IS FREQUENTLY ASSOCIATED WITH DISORDERS OF PERISTALSIS AT HIGH-RESOLUTION MANOMETRY: A PROSPECTIVE SINGLE-CENTRE CASE-CONTROL STUDY
88. AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
89. OC.01.10 EGJ OUTFLOW OBSTRUCTION ACCORDING TO THE NEW CHICAGO CLASSIFICATION: HOW MANY DIAGNOSES MIGHT BE CONFIRMED?
90. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD
91. Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry
92. The distal contractile integral during multiple rapid swallows is inversely correlated with acid exposure time
93. The first 30-min basal impedance levels highly correlate with the 24-h values and lower values are associated with a positive 24-h impedance-pH monitoring
94. Vegetal vs animal food proteins: a different impact in the first post-prandial hour of impedance-pH analysis in patients with reflux disease
95. Novel impedance parameters improve the diagnostic yield of impedance-pH monitoring in reflux disease - a multicenter study
96. Crosstalk between Toll-Like Receptor 4 and dopamine in a mouse model of Dextran Sulfate Sodium-Induced Colitis
97. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
98. Involvement of dopaminergic neurotransmission in small intestine motor dysfunction associated with bowel inflammation in Toll-like receptor 4-null mice
99. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
100. Impact of ciprofloxacin exposure on small bowel excitatory and inhibitory neuromuscular pathways in young adult mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.